Home/Filings/4/0001209191-21-025888
4//SEC Filing

Newell Joe 4

Accession 0001209191-21-025888

CIK 0001604464other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 4:36 PM ET

Size

5.3 KB

Accession

0001209191-21-025888

Insider Transaction Report

Form 4
Period: 2021-04-05
Newell Joe
Chief Tech. Operations Officer
Transactions
  • Sale

    Common Stock

    2021-04-05$14.74/sh655$9,655134,924 total
Footnotes (1)
  • [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1
  • filerCIK 0001702457

Filing Metadata

Form type
4
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:36 PM ET
Size
5.3 KB